Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,683 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fish evacuate smoothly respecting a social bubble.
Larrieu R, Moreau P, Graff C, Peyla P, Dupont A. Larrieu R, et al. Among authors: moreau p. Sci Rep. 2023 Jul 20;13(1):10414. doi: 10.1038/s41598-023-36869-9. Sci Rep. 2023. PMID: 37474571 Free PMC article.
Twice-weekly induction with ixazomib-lenalidomide-dexamethasone (IRd) combination followed by extended IRd consolidation and lenalidomide maintenance in transplant-eligible patients with newly diagnosed multiple myeloma: Results of the phase 2 study IFM2014-03.
Perrot A, Roussel M, Lauwers-Cances V, Hulin C, Leleu X, Touzeau C, Facon T, Mariette C, Schiano JM, Gay J, Montes L, Ranta D, Huguet A, Wuillème S, Dejoie T, Devlamynck L, Corre J, Avet-Loiseau H, Moreau P, Attal M. Perrot A, et al. Among authors: moreau p. Br J Haematol. 2024 May 29. doi: 10.1111/bjh.19570. Online ahead of print. Br J Haematol. 2024. PMID: 38811169
A Common Language For Competency-Based Education.
Moreau P, Koster AS, Crevier F. Moreau P, et al. Am J Pharm Educ. 2024 May 20;88(6):100719. doi: 10.1016/j.ajpe.2024.100719. Online ahead of print. Am J Pharm Educ. 2024. PMID: 38777178 No abstract available.
Transcriptomic and spatial dissection of human ex vivo right atrial tissue reveals proinflammatory microvascular changes in ischemic heart disease.
Linna-Kuosmanen S, Schmauch E, Galani K, Ojanen J, Boix CA, Örd T, Toropainen A, Singha PK, Moreau PR, Harju K, Blazeski A, Segerstolpe Å, Lahtinen V, Hou L, Kang K, Meibalan E, Agudelo LZ, Kokki H, Halonen J, Jalkanen J, Gunn J, MacRae CA, Hollmén M, Hartikainen JEK, Kaikkonen MU, García-Cardeña G, Tavi P, Kiviniemi T, Kellis M. Linna-Kuosmanen S, et al. Among authors: moreau pr. Cell Rep Med. 2024 May 21;5(5):101556. doi: 10.1016/j.xcrm.2024.101556. Cell Rep Med. 2024. PMID: 38776872 Free article.
French early nationwide idecabtagene vicleucel chimeric antigen receptor T-cell therapy experience in patients with relapsed/refractory multiple myeloma (FENIX): A real-world IFM study from the DESCAR-T registry.
Ferment B, Lambert J, Caillot D, Lafon I, Karlin L, Lazareth A, Touzeau C, Leleu X, Moya N, Harel S, Perrot A, Bories P, Vincent L, Lamure S, Mohty M, Malard F, Manier S, Yakoub-Agha I, Schiano De Colella JM, Brisou G, Talbot A, Decaux O, Houot R, Le Gouill S, Bigot N, Facon T, Corre J, Moreau P, Arnulf B; Intergroupe Francophone du Myélome. Ferment B, et al. Among authors: moreau p. Br J Haematol. 2024 May 15. doi: 10.1111/bjh.19505. Online ahead of print. Br J Haematol. 2024. PMID: 38747092
Impact of prior treatment on selinexor, bortezomib, dexamethasone outcomes in patients with relapsed/refractory multiple myeloma: Extended follow-up subgroup analysis of the BOSTON trial.
Mateos MV, Engelhardt M, Leleu X, Mesa MG, Cavo M, Dimopoulos M, Bianco M, Merlo GM, Porte C, Richardson PG, Moreau P. Mateos MV, et al. Among authors: moreau p. Eur J Haematol. 2024 May 1. doi: 10.1111/ejh.14223. Online ahead of print. Eur J Haematol. 2024. PMID: 38693052
1,683 results